Campbell, CA, April 11, 2018 — Dark Horse Consulting (DHC), a leading provider of consulting services for the cell and gene therapy industry, today announced that Katy Spink, Ph.D., Managing Partner, will be presenting at the GTCBio Stem Cell Summit, which is being held in Boston April 12-13.
Dr. Spink’s presentation entitled “It’s the COGS, Stupid! The Importance of Planning for Scalable and Cost Effective Manufacturing for your Cell and Gene Therapy Product” will be presented in the session “Manufacturing and Scalable Processes for Cell Therapy”.
The full conference agenda can be found at:
About Dark Horse Consulting
Dark Horse Consulting (DHC) specializes in providing strategic and operational support for the Cell and Gene Therapy industry. All of our consultants have deep Cell and Gene Therapy industry experience, spanning diverse functions such as process development, device development, manufacturing, quality, regulatory, program management, business development, strategy, and financing/investor relations. Many of our consultants also bring experiences from adjacent more mature sectors, including traditional biologics, small molecules, medical devices, and management consulting. As a result, we deeply understand the unique challenges faced by Cell and Gene Therapy developers and are able to apply best practices from other industries to address the needs of our clients.
Our team of Cell and Gene Therapy professionals brings deep technical expertise to help you tackle the unique challenges of our exciting young field.